Quarterly Financial Information (unaudited and restated) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Quarterly Financial Information Disclosure [Abstract]
Net product sales	$ 56	$ 20	$ 58	$ 46	$ 44	$ 68	$ 62	$ 26	$ 180	$ 200	$ 153
Cost of sales	460	512	547	793	1,392	1,792	2,104	2,213	2,312	7,501	7,804
Gross loss	(404)	(492)	(489)	(747)	(1,348)	(1,724)	(2,042)	(2,187)	(2,132)	(7,301)	(7,651)
Operating expenses	5,763	5,699	6,107	10,253	4,303	11,401	3,777	3,721
Other income (expense)	2,795	179	4,339	(3,009)	(91)	6,520	(8,818)	1,338
Net loss attributable to Fibrocell Science, Inc. common stockholders	$ (3,372)	$ (6,012)	$ (2,257)	$ (14,009)	$ (5,742)	$ (6,605)	$ (14,637)	$ (4,570)	$ (25,650)	$ (31,554)	$ (12,711)
Basic net income (loss) per share (in dollars per share)	$ (0.08)	$ (0.15)	$ (0.06)	$ (0.35)	$ (0.15)	$ (0.24)	$ (0.63)	$ (0.17)	$ (0.63)	$ (1.06)	$ (1.42)
Diluted net income (loss) per share (in dollars per share)	$ (0.09)	$ (0.17)	$ (0.09)	$ (0.35)	$ (0.15)	$ (0.31)	$ (0.63)	$ (0.18)	$ (0.70)	$ (1.12)	$ (2.60)